Table 4.
Treatment | Concentration (ppm) | Consumption (g/day) | RGR (g/g day) | RCR (g/g day) | ECI | FDI (%) |
---|---|---|---|---|---|---|
Control | 0 | 0.386 ± 0.013 * | −0.011 ± 0.01 | 0.316 ± 0.039 a | −9.156 ±1.8 ab | - |
WNT1 | 200 | 0.213 ± 0.001 b,B | −0.002 ± 0.01 | 0.075 ± 0.010 b | −5.213 ± 7.496 | 44.72 a,A |
400 | 0.221 ± 0.001 b,C | −0.012 ± 0.01 | 0.089 ± 0.005 b | −12.146 ± 8.568 | 42.64 a,A | |
600 | 0.206 ± 0.0006 a,A | −0.027 ± 0.01 | 0.101 ± 0.015 b | −27.446 ± 4.889 | 46.52 b,A | |
WNT2 | 200 | 0.178 ± 0.003 a,A | −0.005 ± 0.00 | 0.096 ± 0.015 b | 0.489 ± 5.774 | 53.88 b,B |
400 | 0.189 ± 0.004 a,B | −0.011 ± 0.02 | 0.121 ± 0.043 b | 1.459 ± 14.451 | 50.91 b,B | |
600 | 0.227 ± 0.001 b,C | 0.001 ± 0.02 | 0.116 ± 0.007 b | 3.523 ± 16.979 | 41.14 ab,A | |
WNT4 | 200 | 0.222 ± 0.002 c,A | −0.024 ± 0.01 | 0.109 ± 0.024 b | −21.626 ± 1.375 | 42.49 a,A |
400 | 0.240 ± 0.002 c,B | −0.009 ± 0.00 | 0.081 ± 0.009 b | −11.349 ± 3.949 | 37.64 a,A | |
600 | 0.227 ± 0.0005 b,A | −0.009 ± 0.00 | 0.073 ± 0.004 b | −11.906 ± 1.095 | 41.10 ab,A | |
WNT5 | 200 | 0.229 ± 0.001 c,A | 0.005 ± 0.00 | 0.092 ± 0.003 b | 0.175 ± 2.723 | 40.62 a,A |
400 | 0.237 ± 0.003 c,AB | −0.014 ± 0.01 | 0.102 ± 0.015 b | −11.607 ± 2.622 | 38.58 a,A | |
600 | 0.238 ± 0.0007 c,B | −0.003 ± 0.01 | 0.110 ± 0.008 b | −3.595 ± 4.371 | 38.13 a,A |
The symbol * indicates that it is significantly higher in all the other treatments (p < 0.05). The same small letter indicates that no significant difference exists between the derivatives at the same concentration levels (p > 0.05). The same capital letter indicates that there were no significant differences between concentrations in each derivative (p > 0.05).